Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

This study is currently recruiting participants.
Verified January 2013 by Amneal Pharmaceuticals, LLC
Sponsor:
Collaborator:
Symbio, LLC
Information provided by (Responsible Party):
Amneal Pharmaceuticals, LLC
ClinicalTrials.gov Identifier:
NCT01650051
First received: July 19, 2012
Last updated: January 9, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)